Cardiovascular adverse reactions associated with escitalopram in patients with underlying cardiovascular diseases: a systematic review and meta-analysis

BACKGROUND: Despite the anticipated efficacy of escitalopram in treating depression and anxiety in individuals with preexisting cardiovascular conditions, persistent concerns regarding its adverse effects have emerged. In this systematic review, we aimed to evaluate the cardiovascular safety profile...

Descripción completa

Detalles Bibliográficos
Autores principales: Kimura, Kenichi, Narita, Hisashi, Imai, Hissei, Akiyama, Hisashi, Ishikawa, Shuhei, Sawagashira, Ryo, Isoyama, Tomoyuki, Nohara, Mariko, Kawamura, Michiyo, Kono, Yukari, Saito, Takuya, Kusumi, Ichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10556499/
https://www.ncbi.nlm.nih.gov/pubmed/37810602
http://dx.doi.org/10.3389/fpsyt.2023.1248397

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10556499/
https://www.ncbi.nlm.nih.gov/pubmed/37810602
http://dx.doi.org/10.3389/fpsyt.2023.1248397

Ejemplares similares